- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03820505
Observatory of Unintentional Births Hospital Extras (AIEH34)
Observatory of Unintentional Births Hospital Extras in Hérault
In France, pre-hospital unexpected birth is a rare situation, but over the last ten years, the investigators have seen an increase in the number of these.
For this, the investigators realize an observatory of these deliveries and their care from the call for help and the investigators continue the follow-up and the future of patients and newborns until J7 postpartum.
Study Overview
Status
Conditions
Detailed Description
As a result, the investigators also found a very high variability in the number of deliveries per month for the EMS 34 and the SSSM of the SDIS 34, which can reach up to 11 deliveries per month (May 2014 example).
Formalized expert recommendations were published in 2010 by SFAR, which then led to the establishment of a national observatory for IEA at the end of 2011, in which the investigators have been participating for 4 years.
Currently the national database lists 2000 unannounced deliveries including 230 in the Hérault.
This observational study allows us to evaluate the management of these patients and newborns, the risks and needs of pre-hospital teams, including the need for reinforcement and expertise of midwives.
The investigators can also assess mortality and morbidity, as well as the extension of hospital stays beyond J7
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Christelle GRAF, wise woman
- Phone Number: 33 0677696194
- Email: c-graf@chu-montpellier.fr
Study Locations
-
-
-
Montpellier, France, 34295
- Recruiting
- Uhmontpellier
-
Contact:
- Christelle GRAF, wise woman
- Phone Number: 33 0677696194
- Email: c-graf@chu-montpellier.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Unexpected delivery outside maternity, presence of a medical team during the care
Exclusion Criteria:
- Absence of medicalization
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
number of unexpected hospital deliveries (AIE)
Time Frame: DAY 0 TO DAY 7 TO DELIVRERY
|
Estimate the impact of non-maternal AIE by the SMUR and the SSM in the department of Héraul, and compare it to the national overall activity
|
DAY 0 TO DAY 7 TO DELIVRERY
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Method of taking care of unannounced extra hospital deliveries
Time Frame: DAY 0 TO DAY 7 POST DELIVRERY
|
Method of taking care of unannounced extra hospital deliveries
|
DAY 0 TO DAY 7 POST DELIVRERY
|
Difficulties during an unexpected delivery outside maternity
Time Frame: DAY 0 TO DAY 7 POST DELIVRERY
|
Identify the difficulties during an unexpected delivery outside maternity
|
DAY 0 TO DAY 7 POST DELIVRERY
|
Risks during an unexpected delivery outside maternity
Time Frame: DAY 0 TO DAY 7 POST DELIVRERY
|
Identify the risks during an unexpected delivery outside maternity
|
DAY 0 TO DAY 7 POST DELIVRERY
|
Possible immediate complications during an unexpected delivery outside maternity
Time Frame: DAY 0 TO DAY 7 POST DELIVRERY
|
Identify the possible immediate complications during an unexpected delivery outside maternity
|
DAY 0 TO DAY 7 POST DELIVRERY
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Christelle GRAF, wise woman, University Hospital, Montpellier
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- RECHMPL18_0442
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.